Production of scatter factor-like activity by a nitrosamine-induced pancreatic cancer cell line.
Two hamster pancreatic cancer cell lines, PC-1 and PC1.0, established from N-nitrosobis(2-oxopropyl)amine-induced pancreatic ductal/ductular adenocarcinomas exhibit different growth patterns. PC-1 cells, which produce well differentiated adenocarcinomas in vitro after allogeneic inoculation, form cell aggregates and characteristic island-like structures in vitro. PC1.0 cells, which produce poorly differentiated tumors in vivo, form dispersed colonies in vitro. Conditioned medium prepared from PC1.0 cells inhibits PC-1 cells from forming island-like colonies. The conditioned medium also prevents several human pancreatic carcinoma cell lines, HPAF, CD11 and CD18, from forming compact colonies. These properties are similar to those described previously as scatter factors. The scatter factor-like activity is heat-labile, acid-stable, non-dialyzable, trypsin sensitive and unaffected by reducing agents. The activity is not suppressed by addition of heparin, and it does not bind to heparin. In addition, the scatter phenomenon is not reproduced by acidic or basic fibroblast growth factor, epidermal growth factor or transforming growth factor-beta 1. Based on these findings, it appears that the scattering activity produced by PC1.0 cells differs from the scatter factors that have been identified in other systems.
Hirota
M
M
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha 68198-6805.
Egami
H
H
Corra
S
S
Fujii
H
H
Chaney
W G
WG
Rizzino
A
A
Pour
P M
PM
D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology; D000818:Animals; D002273:Carcinogens; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000378:metabolism*; D002448:Cell Adhesion / Q000187:drug effects / Q000502:physiology; D002449:Cell Aggregation / Q000187:drug effects / Q000502:physiology; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D006224:Cricetinae; D003470:Culture Media; D006133:Growth Substances / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology; D017228:Hepatocyte Growth Factor / Q000096:biosynthesis* / Q000378:metabolism / Q000502:physiology; D006801:Humans; D009602:Nitrosamines; D010190:Pancreatic Neoplasms / Q000378:metabolism* / Q000473:pathology; D014407:Tumor Cells, Cultured
D002273:Carcinogens; D003470:Culture Media; D006133:Growth Substances; D009602:Nitrosamines; C013622:nitrosobis(2-oxopropyl)amine; D017228:Hepatocyte Growth Factor; D006493:Heparin